TL;DR
This study compares two ultrasound-guided biopsy techniques for oral masses: transoral and transcutaneous. The transoral approach demonstrated comparable diagnostic efficacy to the transcutaneous method but with significantly fewer post-procedural complications, suggesting it may be a safer and more effective standard for oral lesion biopsy.
What Problem Does This Paper Address?
Accurate and timely diagnosis of oral lesions is crucial for effective treatment and improved patient outcomes, especially for oral cancers where delayed diagnosis leads to significantly lower survival rates. While imaging modalities like CT and MRI have limitations (artifacts, time, cost), ultrasound offers high resolution and accessibility. However, traditional biopsy methods like incisional biopsy can be challenging for deep or submucosal tumors, sometimes yielding inadequate or false-negative results. Ultrasound-guided transcutaneous biopsy is established but can be hindered by anatomical factors like oral gas and bone. Ultrasound-guided transoral biopsy is a newer technique, offering direct access to oral structures, but its comparative efficacy and safety against the more established transcutaneous approach for oral masses needed rigorous investigation. This paper aims to fill that gap by directly comparing these two ultrasound-guided methods.
Methods
This prospective randomized controlled trial enrolled 134 patients with oral masses, with 131 ultimately included in the analysis (66 in the transoral group and 65 in the transcutaneous group). Patients were randomly assigned to undergo either ultrasound-guided transoral core needle biopsy (CNB) or ultrasound-guided transcutaneous CNB via a submental approach.
Key procedural aspects included:
- Transoral CNB: Performed using an endocavitary transducer (10 MHz or 5-9 MHz) inserted via transoral access. Color Doppler and contrast-enhanced sonography were used to identify viable tissue and avoid critical structures. An 18-gauge automatic core biopsy needle was used.
- Transcutaneous CNB: Performed using a linear probe (5-12 MHz) from a submental approach, with the neck extended. Similar imaging techniques and an 18-gauge automatic core biopsy needle were employed.
Data collected and compared included:
- Diagnostic performance: Assessed by comparing biopsy histology with final histology from surgical resection. Metrics included sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy.
- Intra-operative blood loss: Estimated visually.
- Oral pain: Evaluated using the Visual Analogue Scale (VAS) before and after the procedure.
- Biopsy time: Measured from the first puncture to needle removal.
- Complications: Systematically documented, including hematoma, edema, inflammation, erythema, ecchymosis, numbness, denervation, atrophy, and abnormal scarring. Specific attention was paid to acute submandibular sialadenitis.
Datasets
Not discussed in the paper. The study utilized patient data collected prospectively during the trial.
Key Insights and Ideas
- Transoral Biopsy's Safety Advantage: The most striking finding is the significantly lower rate of post-procedural complications with the transoral approach (0%) compared to the transcutaneous approach (24%). This difference was primarily driven by a lower incidence of acute submandibular sialadenitis in the transoral group.
- Comparable Diagnostic Efficacy: Despite the safety difference, the transoral approach achieved diagnostic accuracy (95.2%) comparable to the transcutaneous approach (88%), suggesting it is not a trade-off between safety and diagnostic yield.
- Direct Visualization: The transoral approach's ability to directly visualize oral structures, bypassing interfering factors like oral gas and subcutaneous layers, is highlighted as a key advantage for precise targeting and reducing damage to adjacent tissues.
- Technical Feasibility: While transcutaneous biopsy was hindered in some cases by unclear imaging paths or proximity to major vessels, the transoral method proved technically feasible and less prone to these specific issues.
Key Results
- Complications: The transcutaneous group experienced a significantly higher postprocedural complication rate (24%) compared to the transoral group (0%) (P=0.000). Specifically, 12 out of 50 patients in the transcutaneous group developed acute submandibular sialadenitis.
- Diagnostic Accuracy: The transoral group achieved an accuracy of 95.2%, while the transcutaneous group achieved 88% (P=0.30). Sensitivity, specificity, PPV, and NPV were also reported for both groups, showing generally high performance for both.
- Biopsy Time: No significant difference was found in biopsy time between the groups (76 ± 12 s vs. 80 ± 13 s, p=0.09).
- Blood Loss: Intra-operative blood loss was similar between the groups (2.6 ± 0.5 mL vs. 2.7 ± 0.4 mL, p=0.17).
- Pain: No significant difference in VAS scores was observed between the groups, either before or after the procedure.
- Procedure Termination: No biopsies were terminated early due to pain or bleeding in either group.
Limitations and Future Work
The authors acknowledge several limitations:
- Sample Size and Variety: The study had a limited number and variety of cases, suggesting that larger, multi-center studies are needed to further validate the findings.
- Operator Experience: The transoral approach is described as a novel technique whose application is dependent on operator experience, implying a learning curve.
Future work could focus on expanding these studies to larger, more diverse patient populations and potentially exploring the learning curve associated with the transoral technique. The authors suggest that their findings provide evidence to support the transoral approach as a standard for image-guided biopsy in patients with oral lesions.
Summary updated